MetaCap

Progyny Inc. Company Profile

NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD

27.55+1.64 (+6.33%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Progyny at a glance

Progyny Inc. (NASDAQ: PGNY) is a Misc Health and Biotechnology Services company in the Health Care sector headquartered in New York, NY. Progyny is led by Mr. Peter Anevski CPA and employs about 835 people. The company's shares have traded publicly since 2019.

At a market capitalization of $2.11 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001551306, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Progyny do?

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Business description based on the company's public filings.

Company information

Legal name
Progyny Inc.
Ticker
NASDAQ: PGNY
Industry
Misc Health and Biotechnology Services
CEO
Mr. Peter Anevski CPA
Employees
835
Headquarters
1359 Broadway, New York, NY, United States
Phone
212 888 3124
IPO year
2019
SEC CIK
0001551306
Latest annual report
10-K · Feb 27, 2026

Companies similar to Progyny

PGNY peer companies
CompanyPrice% ChgMarket capCompare
PARKPark Dental Partners Inc.20.94+1.26%$99.58Mvs PGNY
CCELCryo-Cell International Inc.3.91+0.77%$31.52Mvs PGNY
MGRXMangoceuticals Inc.0.4437-1.40%$9.57Mvs PGNY
NIVFNewGenIvf Group Limited Class A0.106+7.40%$2.89Mvs PGNY
SHCSotera Health Company17.90-1.92%$5.11Bvs PGNY
FMSFresenius Medical Care AG ADR20.69-7.72%$11.01Bvs PGNY
DVADaVita Inc.176.78-2.01%$11.28Bvs PGNY

Related